Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings Inc. | 4 | 0 | 1 | 0 | €1.63 | €4.39 | 169.240% |
| Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.00 | €19.86 | 231.082% |
| Viking Therapeutics Inc | 4 | 1 | 0 | 1 | €69.44 | €140.00 | 101.613% |
| Actinium Pharmaceuticals Inc. | 3 | 0 | 1 | 0 | €6.44 | €8.50 | 32.090% |
| Vitrolife AB | 3 | 0 | 0 | 0 | €13.96 | - | - |
| Immunic Inc. | 6 | 3 | 1 | 3 | €1.15 | €5.48 | 378.760% |
| Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €48.90 | €57.50 | 17.587% |
| Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.70 | 168.304% |
| ImmunityBio Inc. | 3 | 0 | 1 | 0 | €6.87 | €10.00 | 45.645% |
| Innoviva Inc. | 3 | 0 | 2 | 0 | €14.20 | €30.00 | 111.268% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €209.00 | - | - |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €67.06 | €100.00 | 49.120% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.00 | €15.50 | 158.506% |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
| Stratec SE | 2 | 0 | 0 | 0 | €42.10 | - | - |
| Edap Tms S.A. ADR | 3 | 1 | 1 | 0 | €6.80 | €14.79 | 117.529% |
| Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.25 | €8.27 | 32.365% |
| Clinica Baviera S.A. | 2 | 0 | 0 | 0 | €27.90 | - | - |
| Codexis Inc. | 4 | 2 | 0 | 0 | €2.48 | €8.35 | 236.738% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €61.30 | €80.00 | 30.506% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.51 | €7.00 | 99.544% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.67 | - | - |
| Affimed N.V. | 8 | 6 | 3 | 0 | €0.55 | €6.54 | 1083.165% |
| M1 Kliniken AG | 2 | 0 | 0 | 0 | €13.30 | - | - |